FDA/EMEA To Hold Joint Pharmacogenomic Meetings
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA and the European Medicines Agency will offer voluntary genomic data submission sponsors the option of joint FDA/EMEA briefing meetings, the agencies said May 31